Tactile Medical Technology Announces That Nimbl, Its Next-Generation Pneumatic Compression Platform, Is Now Commercially Available Throughout The U.S. For The Treatment Of Upper Extremity Lymphedema
Portfolio Pulse from Benzinga Newsdesk
Tactile Systems Technology, Inc. (NASDAQ:TCMD) has announced the commercial availability of Nimbl, its next-generation pneumatic compression platform, in the U.S. for treating upper extremity lymphedema. Nimbl is smaller and lighter than previous models and has received FDA clearance and CMS approval.
October 02, 2024 | 12:14 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Tactile Systems Technology has launched Nimbl, a new pneumatic compression platform for upper extremity lymphedema, now available in the U.S. This product launch follows FDA clearance and CMS approval, potentially boosting TCMD's market presence.
The launch of Nimbl, a new product with FDA clearance and CMS approval, is likely to positively impact TCMD's stock as it expands the company's product offerings and market reach. The product's smaller and lighter design may attract more customers, enhancing sales and revenue potential.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100